Influential Bond University professor Paul Glasziou has again been named on a list of the world's most cited researchers.
Twenty-three Nobel laureates are among those recognised this year and all on the list have authored multiple papers ranking in the top 1 per cent by citations for their field and year of publication.
Professor Glasziou is the Director of Bond University’s Institute for Evidence-Based Healthcare, a world-leading research centre in the realm of evidence-based practice.
His latest paper, The Burden of Cancer Overdiagnosis in Australia, is due to be published soon.
“We aim to improve communication between clinicians and researchers, and provide a clearer understanding of the causes of, and solutions to, gaps between research evidence and its application in practice,” Professor Glasziou said.
“Our primary focuses include promoting effective non-pharmaceutical interventions for patients, ways to reduce the over-use of antibiotics to reduce antimicrobial resistance, and reducing overdiagnosis.
“All these are important to better and more sustainable health care.”
Bond University Deputy Vice Chancellor (Academic), Professor Keitha Dunstan, said the honour capped a significant year for Professor Glasziou.
In June the institute, founded as the Centre for Research and Evidence-Based Practice, evolved into the Institute for Evidence-Based Healthcare and moved into purpose-built premises in the university’s expanded Faculty of Health Sciences and Medicine.
“Under Professor Glasziou’s leadership over the past 10 years, the Institute has developed an international reputation for excellence in its field,” Professor Dunstan said.
In September Professor Glasziou was named as a recipient of a highly prestigious National Health and Medical Research Council Investigator Fellowship with a $2.7 million grant.
“The work of Professor Glasziou and his colleagues will undoubtedly help to shape global healthcare in the 21st century,” Professor Dunstan said.